• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Ginkgolic Acid (13:0)

Ginkgolic Acid (13:0)

Product ID G3352
Cas No. 20261-38-5
Purity ≥98%
Product Unit SizeCostQuantityStock
1 mg $215.00 In stock
5 mg $525.00 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Ginkgolic acids are found in Ginkgo biloba and exhibit antiviral, antibiotic, and anticancer chemotherapeutic activities. In vitro, ginkgolic acids inhibit HIV protease and suppress HIV infection. Ginkgolic acids also exhibit antibacterial activity against both gram positive and gram negative bacteria, including Staphylococcus, Escherichia, and Bacillus. Ginkgolic acids also inhibit fatty acid synthase and exhibit cytotoxicity in breast cancer, lung cancer, and leukemia cells. Additionally, ginkgolic acids induce apoptosis in cancer cells through downregulation of Bcl-2 and upregulation of Bax. Ginkgolic acids may also be neurotoxic, as they increase activity of protein phosphatase 2C (PP2C) in neurons.

Product Info

Cas No.

20261-38-5

Purity

≥98%

Formula

C20H32O3

Formula Wt.

320.47

IUPAC Name

2-hydroxy-6-tridecylbenzoic acid

Synonym

6-n-Tridecylsalicylic acid, Ginkgoneolic acid

Appearance

White Crystal Powder

Shipping and Storage

Store Temp

-20°C

Ship Temp

Ambient

Downloads

MSDS

G3352 MSDS PDF

Info Sheet

G3352 Info Sheet PDF

Brochures

Antivirals Booklet

References

Fu Y, Hong S, Li D, et al. Novel chemical synthesis of ginkgolic acid (13:0) and evaluation of its tyrosinase inhibitory activity. J Agric Food Chem. 2013 Jun 5;61(22):5347-52. PMID: 23701207.

Oh J, Hwang IH, Hong CE, et al. Inhibition of fatty acid synthase by ginkgolic acids from the leaves of Ginkgo biloba and their cytotoxic activity. J Enzyme Inhib Med Chem. 2013 Jun;28(3):565-8. PMID: 22380770.

Lü JM, Yan S, Jamaluddin S, et al. Ginkgolic acid inhibits HIV protease activity and HIV infection in vitro. Med Sci Monit. 2012 Aug;18(8):BR293-298. PMID: 22847190.

Zhou C, Li X, Du W, et al. Antitumor effects of ginkgolic acid in human cancer cell occur via cell cycle arrest and decrease the Bcl-2/Bax ratio to induce apoptosis. Chemotherapy. 2010;56(5):393-402. PMID: 20948210.

Yang X, Chen J, Qian Z, et al. Study on the antibacterial activity of ginkgolic acids. Zhong Yao Cai. 2002 Sep;25(9):651-3. PMID: 12451978.

Ahlemeyer B, Selke D, Schaper C, et al. Ginkgolic acids induce neuronal death and activate protein phosphatase type-2C. Eur J Pharmacol. 2001 Oct 26;430(1):1-7. PMID: 11698056.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • K1676

    Ketoconazole

    Imidazole; 14-α demethylase inhibitor.

    ≥98%
  • V5725

    Voglibose

    α-glucosidase inhibitor, potential GLP-1 agoni...

    ≥99%
  • P0256

    Pantoprazole Sodium Sesquihydrate

    H+/K+ ATPase and ROCK-2 inhibitor.

    ≥98%
  • P2100

    PF-06447475

    LRRK2 inhibitor.

    ≥98%
  • I7478

    Istradefylline

    Adenosine A2A antagonist.

    ≥99%
  • E7556

    Etodolac

    NSAID; TRPA1 agonist, COX-2 inhibitor.

    ≥98%
  • G7346

    GSK-2636771

    p110β PI3K inhibitor.

    ≥98%
  • C104761

    CCT-196969

    pan-Raf inhibitor.

    ≥98%
  • A6800

    AR-A014418

    GSK-3β inhibitor.

    ≥98%
  • L1628

    Ac-LEHD-pNa

    Caspase 9 substrate.

    ≥95%
  • A4678

    Alternariol-9-methyl Ether

    Mycotoxin produced by Alternaria; oxidative pho...

    ≥98%
  • A1017

    Aceclofenac

    Diclofenac analog, NSAID; COX-2 inhibitor.

    ≥98%
  • P3456

    Pimobendan

    PDE3 inhibitor.

    ≥99%
  • G1210

    GDC-0623

    MEK inhibitor.

    ≥98%
  • E846184

    Everolimus EP Impurity B

    Everolimus impurity

    ≥96% (mix of E/Z)
  • R4132

    RKI-1447

    ROCK1/2 inhibitor.

    ≥98%
  • C6957

    Croton Oil

    Mixture found in Croton, used to induce inflamm...

  • H9718

    2-Hydroxyflutamide

    Non-steroid; AR antagonist.

    ≥98%
  • D6958

    Droloxifene Citrate

    Tamoxifen analog; SERM.

    ≥98%
  • T3196

    Thymoquinone

    Phytochemical from Nigella sativa.

    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2026 LKT Laboratories, All Rights Reserved - Products for research use only